| 1 | Lymphoma, Follicular | 48.9% |
| 2 | Mantle cell lymphoma | 48.9% |
| 3 | Lymphoma, AIDS-Related | 36.5% |
| 4 | Primary Effusion Lymphoma | 36.5% |
| 5 | Hodgkin Disease | 35.5% |
| 6 | Composite Lymphoma | 34.7% |
| 7 | Lymphomatoid Granulomatosis | 34.1% |
| 8 | Plasmablastic lymphoma | 30.3% |
| 9 | Burkitt Lymphoma | 27.6% |
| 10 | Tumor Lysis Syndrome | 22.7% |
| 11 | Autoimmune Lymphoproliferative Syndrome | 18.8% |
| 12 | Infectious Mononucleosis | 17.4% |
| 13 | Plasmacytoma | 17.2% |
| 14 | Primary amyloidosis | 15.8% |
| 15 | Lymphangioleiomyomatosis | 15.1% |
| 16 | Histiocytic Disorders, Malignant | 14.8% |
| 17 | Leukemia, T-Cell | 14.4% |
| 18 | Leukemia, B-Cell | 14.4% |
| 19 | Heavy Chain Disease | 14.3% |
| 20 | Sarcoidosis | 14.1% |
| 21 | Sezary Syndrome | 14% |
| 22 | Leukemia, Plasma Cell | 13.7% |
| 23 | Agammaglobulinemia | 13.5% |
| 24 | Waldenstrom Macroglobulinemia | 13.4% |
| 25 | Multiple Myeloma | 13.4% |
| 26 | Lymphocele | 12.3% |
| 27 | leukemia | 12.3% |
| 28 | Neoplasms, Germ Cell and Embryonal | 12.3% |
| 29 | Neoplasms, Glandular and Epithelial | 12.3% |
| 30 | Germ Cell Cancer | 12.3% |
| 31 | Neuroectodermal Tumors | 11.7% |
| 32 | Granuloma | 11.5% |
| 33 | Neoplasms, Neuroepithelial | 11.3% |
| 34 | Gliomatosis cerebri | 11.3% |
| 35 | Adenitis | 11.1% |
| 36 | Histiocytosis | 11.1% |
| 37 | Lymphadenitis | 11.1% |
| 38 | Lymphangitis | 11.1% |
| 39 | Lymphedema | 11.1% |
| 40 | Splenic Diseases | 11.1% |
| 41 | Thymus Hyperplasia | 11.1% |
| 42 | Pseudolymphoma | 11.1% |
| 43 | Lymphadenopathy | 11.1% |
| 44 | Thymus Neoplasms | 10.9% |
| 45 | Paraproteinemias | 10.5% |
| 46 | Thymoma | 10% |
| 47 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 9.8% |
| 48 | Leukemia, Large Granular Lymphocytic | 9.8% |
| 49 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 9.8% |
| 50 | Carcinosarcoma | 9.7% |
| 51 | Hemangiosarcoma | 9.7% |
| 52 | lymphangiosarcoma | 9.7% |
| 53 | melanoma | 9.6% |
| 54 | Meningioma | 9% |
| 55 | Lymphatic Abnormalities | 9% |
| 56 | Transfusion Reaction | 8.9% |
| 57 | Hypotensive Transfusion Reaction | 8.9% |
| 58 | Hypergammaglobulinemia | 8.9% |
| 59 | Malignant histiocytosis | 8.7% |
| 60 | Histiocytic sarcoma | 8.7% |
| 61 | Medulloblastoma | 8.5% |
| 62 | Carcinoma 256, Walker | 8.4% |
| 63 | Monoclonal Gammopathy of Undetermined Significance | 8.3% |
| 64 | Splenic Neoplasms | 8.2% |
| 65 | Lymphangiectasis, Intestinal | 8.2% |
| 66 | Adenoma, Acidophil | 8% |
| 67 | Ganglioneuroma | 8% |
| 68 | Glioma | 8% |
| 69 | Malignant Glioma | 8% |
| 70 | Basal cell carcinoma | 7.7% |
| 71 | Carcinoma, Papillary | 7.7% |
| 72 | Squamous cell carcinoma | 7.7% |
| 73 | Chondrosarcoma | 7.7% |
| 74 | Craniopharyngioma | 7.7% |
| 75 | Cystadenoma | 7.7% |
| 76 | leiomyosarcoma | 7.7% |
| 77 | liposarcoma | 7.7% |
| 78 | Mesothelioma | 7.7% |
| 79 | synovial sarcoma | 7.7% |
| 80 | Trophoblastic Neoplasms | 7.7% |
| 81 | Neuroectodermal Tumor, Melanotic | 7.7% |
| 82 | Angiomyolipoma | 7.7% |
| 83 | Clear Cell Sarcoma of Soft Tissue | 7.7% |
| 84 | Alveolar Soft Part Sarcoma | 7.7% |
| 85 | Neuroendocrine Tumors | 7.7% |
| 86 | Sarcoma, Myeloid | 7.7% |
| 87 | Carcinoma, Basal Cell | 7.7% |
| 88 | Leukemia, Experimental | 7.7% |
| 89 | Hamartoma | 7.6% |
| 90 | Neoplasms, Hormone-Dependent | 7.6% |
| 91 | Neoplasms, Multiple Primary | 7.6% |
| 92 | Paraneoplastic Syndromes | 7.6% |
| 93 | Precancerous Conditions | 7.6% |
| 94 | Neoplasms, Second Primary | 7.6% |
| 95 | Melanoma, Experimental | 7.5% |
| 96 | Mucocutaneous Lymph Node Syndrome | 7.4% |
| 97 | Adenoma | 7.3% |
| 98 | Ameloblastoma | 7.3% |
| 99 | Angiokeratoma | 7.3% |
| 100 | Carcinoma | 7.3% |
| 101 | Chordoma | 7.3% |
| 102 | Hemangioma | 7.3% |
| 103 | hemangiopericytoma | 7.3% |
| 104 | Lymphangioma | 7.3% |
| 105 | Mesenchymoma | 7.3% |
| 106 | Nevus | 7.3% |
| 107 | Teratoma | 7.3% |
| 108 | Hepatoblastoma | 7.3% |
| 109 | Mixed Tumor, Mullerian | 7.3% |
| 110 | Germinoma | 7.3% |
| 111 | Teratocarcinoma | 7.3% |
| 112 | Angiofibroma | 7.3% |
| 113 | Sarcoma | 7.3% |
| 114 | Epithelioma | 7.3% |
| 115 | Autoimmune Diseases | 7.2% |
| 116 | Hypersensitivity | 7.2% |
| 117 | Immunologic Deficiency Syndromes | 7.2% |
| 118 | Immune reconstitution syndrome | 7.2% |
| 119 | Immune Reconstitution Inflammatory Syndrome | 7.2% |
| 120 | Carcinoma, Ehrlich Tumor | 7.2% |
| 121 | Dermoid Cyst | 7.2% |
| 122 | Carcinoma, Lewis Lung | 7.2% |
| 123 | Carcinoid Tumor | 7.2% |
| 124 | Neurilemmoma | 7.2% |
| 125 | Hutchinson's Melanotic Freckle | 7.2% |
| 126 | Melanoma, Amelanotic | 7.2% |
| 127 | Sarcoidosis, Pulmonary | 6.8% |
| 128 | Cystadenocarcinoma | 6.7% |
| 129 | Fibrosarcoma | 6.7% |
| 130 | Osteosarcoma | 6.7% |
| 131 | Mucoepidermoid Carcinoma | 6.7% |
| 132 | Leukemia, Radiation-Induced | 6.6% |
| 133 | Astrocytoma | 6.3% |
| 134 | Ependymoma | 6.3% |
| 135 | oligodendroglioma | 6.3% |
| 136 | Ganglioglioma | 6.3% |
| 137 | gliosarcoma | 6.3% |
| 138 | Anaplastic astrocytoma | 6.3% |
| 139 | Anaplastic Oligodendroglioma | 6.3% |
| 140 | Hematologic Neoplasms | 6.3% |
| 141 | Adenofibroma | 6.2% |
| 142 | Fibroadenoma | 6.2% |
| 143 | Malignant Fibrous Histiocytoma | 6.2% |
| 144 | Choriocarcinoma | 6.2% |
| 145 | Carcinoma, Lobular | 6.2% |
| 146 | Cyst | 6.2% |
| 147 | Neoplastic Processes | 6.2% |
| 148 | Neoplastic Syndromes, Hereditary | 6.2% |
| 149 | Pregnancy Complications, Neoplastic | 6.2% |
| 150 | Endometrial Stromal Sarcoma | 6.2% |
| 151 | Neoplasms, Experimental | 6.1% |
| 152 | Elephantiasis | 6% |
| 153 | Hypersplenism | 6% |
| 154 | Elephantiasis Nostras Verrucosa | 6% |
| 155 | Sarcoma, Experimental | 6% |
| 156 | Malignant Carcinoid Syndrome | 5.9% |
| 157 | Leukemia L1210 | 5.8% |
| 158 | Leukemia P388 | 5.8% |
| 159 | Acanthoma | 5.8% |
| 160 | Bowen's Disease | 5.7% |
| 161 | Paraganglioma | 5.7% |
| 162 | Rhabdomyosarcoma | 5.7% |
| 163 | Giant Cell Tumor of Bone | 5.7% |
| 164 | Glioblastoma | 5.5% |
| 165 | Neuroblastoma | 5.5% |
| 166 | Glioblastoma Multiforme | 5.5% |
| 167 | Retinoblastoma | 5.5% |
| 168 | Multiple Endocrine Neoplasia | 5.5% |
| 169 | Dermatofibrosarcoma | 5.2% |
| 170 | Dermatofibrosarcoma Protuberans | 5.2% |
| 171 | Ganglioneuroblastoma | 5.1% |
| 172 | Neoplasms, Radiation-Induced | 5.1% |
| 173 | Neurofibrosarcoma | 5.1% |
| 174 | Splenic Infarction | 4.9% |
| 175 | Histiocytosis, Langerhans-Cell | 4.9% |
| 176 | Cryoglobulinemia | 4.9% |
| 177 | Sarcoma 180 | 4.8% |
| 178 | Leukemia, Myelomonocytic, Chronic | 4.8% |
| 179 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.8% |
| 180 | Adenocarcinoma | 4.8% |
| 181 | Carcinoma in Situ | 4.8% |
| 182 | Carcinoma, Transitional Cell | 4.8% |
| 183 | Phyllodes Tumor | 4.8% |
| 184 | Dysgerminoma | 4.8% |
| 185 | Hemangioendothelioma | 4.8% |
| 186 | Lipoma | 4.8% |
| 187 | Myoma | 4.8% |
| 188 | Myxoma | 4.8% |
| 189 | Neuroma | 4.8% |
| 190 | Papilloma | 4.8% |
| 191 | Pseudomyxoma Peritonei | 4.8% |
| 192 | Seminoma | 4.8% |
| 193 | Papillomatosis | 4.8% |
| 194 | Angiolipoma | 4.8% |
| 195 | Myelolipoma | 4.8% |
| 196 | Neoplasms, Bone Tissue | 4.8% |
| 197 | Neoplasms, Fibrous Tissue | 4.8% |
| 198 | Smooth Muscle Tumor | 4.8% |
| 199 | Adenomatosis, Pulmonary | 4.8% |
| 200 | Adenomatous Polyps | 4.8% |
| 201 | Carcinoma, Large Cell | 4.8% |
| 202 | Carcinoma, Small Cell | 4.8% |
| 203 | Desmoplastic Small Round Cell Tumor | 4.8% |
| 204 | Chondroma | 4.8% |
| 205 | Enchondroma | 4.8% |
| 206 | Pheochromocytoma | 4.8% |
| 207 | Alveolar rhabdomyosarcoma | 4.8% |
| 208 | Glomerulonephritis, Membranoproliferative | 4.7% |
| 209 | Carcinoid Heart Disease | 4.7% |
| 210 | Mastocytosis | 4.6% |
| 211 | Nephroblastoma | 4.6% |
| 212 | Thrombocytopenic purpura | 4.5% |
| 213 | Paraneoplastic Encephalomyelitis | 4.4% |
| 214 | Mammary Neoplasms, Experimental | 4.4% |
| 215 | Bone Marrow Neoplasms | 4.3% |
| 216 | Autoimmune thrombocytopenia | 4.3% |
| 217 | Immune thrombocytopenic purpura | 4.3% |
| 218 | Basal Cell Nevus Syndrome | 4.2% |
| 219 | Tuberous Sclerosis | 4.2% |
| 220 | Splenic Rupture | 4.2% |
| 221 | POEMS Syndrome | 4.2% |
| 222 | Abdominal Neoplasms | 4.1% |
| 223 | Erythroplasia | 4.1% |
| 224 | Follicular cyst | 4.1% |
| 225 | Head and Neck Neoplasms | 4.1% |
| 226 | Mucocele | 4.1% |
| 227 | Pilonidal Cyst | 4.1% |
| 228 | Soft Tissue Neoplasms | 4.1% |
| 229 | Thoracic Neoplasms | 4.1% |
| 230 | Thyroglossal Cyst | 4.1% |
| 231 | Synovial Cyst | 4.1% |
| 232 | Aberrant Crypt Foci | 4.1% |
| 233 | Disseminated Intravascular Coagulation | 4.1% |
| 234 | Protein S Deficiency | 4.1% |
| 235 | Hemangioma, Cavernous | 4% |
| 236 | Acoustic Neuroma | 4% |
| 237 | Carcinoma, Pancreatic Ductal | 4% |
| 238 | Lymphopenia | 3.9% |
| 239 | Mastocytosis, Systemic | 3.8% |
| 240 | Transfusion-Related Acute Lung Injury | 3.8% |
| 241 | Mesoblastic Nephroma | 3.7% |
| 242 | Hepatocellular Adenoma | 3.7% |
| 243 | Anemia | 3.7% |
| 244 | Blood Coagulation Disorders | 3.7% |
| 245 | Blood Platelet Disorders | 3.7% |
| 246 | Bone Marrow Diseases | 3.7% |
| 247 | Hemorrhagic Disorders | 3.7% |
| 248 | Immune Complex Diseases | 3.7% |
| 249 | Leukocyte Disorders | 3.7% |
| 250 | Methemoglobinemia | 3.7% |
| 251 | Pancytopenia | 3.7% |
| 252 | Polycythemia | 3.7% |
| 253 | Sulfhemoglobinemia | 3.7% |
| 254 | Antiphospholipid Syndrome | 3.7% |
| 255 | Thrombophilia | 3.7% |
| 256 | Latex allergy | 3.7% |
| 257 | Erythrocytosis | 3.7% |
| 258 | Optic Nerve Glioma | 3.6% |
| 259 | Lymphohistiocytosis, Hemophagocytic | 3.6% |
| 260 | Schnitzler Syndrome | 3.6% |
| 261 | Erdheim-Chester Disease | 3.6% |
| 262 | Adenoid Cystic Carcinoma | 3.6% |
| 263 | fibroma | 3.6% |
| 264 | Fibromatosis | 3.6% |
| 265 | Osteoblastoma | 3.6% |
| 266 | Osteoma | 3.6% |
| 267 | Rhabdomyoma | 3.6% |
| 268 | Chondromatosis | 3.6% |
| 269 | Adenocarcinoma, Clear Cell | 3.6% |
| 270 | Cholangiocarcinoma | 3.6% |
| 271 | Cervical Intraepithelial Neoplasia | 3.6% |
| 272 | Hemangioblastoma | 3.6% |
| 273 | Leukemia, Myeloid, Chronic-Phase | 3.5% |
| 274 | Thrombocythemia, Essential | 3.5% |
| 275 | Hydatidiform Mole | 3.5% |
| 276 | Digestive System Neoplasms | 3.4% |
| 277 | Endocrine Gland Neoplasms | 3.4% |
| 278 | Eye Neoplasms | 3.4% |
| 279 | Nervous System Neoplasms | 3.4% |
| 280 | Vipoma | 3.3% |
| 281 | Bone neoplasms | 3.3% |
| 282 | Leukoplakia | 3.3% |
| 283 | Pancreatic Cyst | 3.3% |
| 284 | Skin Neoplasms | 3.3% |
| 285 | Barrett Esophagus | 3.3% |
| 286 | Breast Cyst | 3.3% |
| 287 | Actinic keratosis | 3.3% |
| 288 | Mediastinal Cyst | 3.3% |
| 289 | Neoplasm Invasiveness | 3.3% |
| 290 | Neoplasm Metastasis | 3.3% |
| 291 | Neoplasm Recurrence, Local | 3.3% |
| 292 | Parovarian Cyst | 3.3% |
| 293 | Pericardial Cyst | 3.3% |
| 294 | Thymic Cyst | 3.3% |
| 295 | Carcinogenesis | 3.3% |
| 296 | Myxoid cyst | 3.3% |
| 297 | Metastasis | 3.3% |
| 298 | Sturge-Weber Syndrome | 3.3% |
| 299 | Multiple Endocrine Neoplasia Type 1 | 3.3% |
| 300 | Gastrointestinal Stromal Tumors | 3.2% |
| 301 | Prolactinoma | 3.2% |
| 302 | Growth Hormone-Secreting Pituitary Adenoma | 3.2% |
| 303 | neurofibroma | 3.2% |
| 304 | Environmental Illness | 3.1% |
| 305 | Thrombasthenia | 3% |
| 306 | Antithrombin III Deficiency | 3% |
| 307 | Protein C Deficiency | 3% |
| 308 | Lupus Erythematosus, Systemic | 3% |
| 309 | Pregnancy Complications, Hematologic | 3% |
| 310 | Overlap syndrome | 3% |
| 311 | Fibromatosis, Aggressive | 3% |
| 312 | Fibromatosis, Abdominal | 3% |
| 313 | Klatskin Tumor | 3% |
| 314 | Polycythemia Vera | 3% |
| 315 | Addison Disease | 3% |
| 316 | Pemphigus | 3% |
| 317 | Autoimmune thyroiditis | 3% |
| 318 | Primary Adrenal Insufficiency | 3% |
| 319 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.9% |
| 320 | Autoimmune hepatitis | 2.9% |
| 321 | Mastocytoma | 2.9% |
| 322 | Adenomatous Polyposis Coli | 2.9% |
| 323 | Liver Neoplasms, Experimental | 2.9% |
| 324 | Parathyroid Neoplasms | 2.9% |
| 325 | Peritoneal Neoplasms | 2.9% |
| 326 | Thyroid Neoplasm | 2.9% |
| 327 | Thyroid carcinoma | 2.9% |
| 328 | granulosa cell tumor | 2.9% |
| 329 | Carcinoma, Ovarian Epithelial | 2.9% |
| 330 | Lambert-Eaton Myasthenic Syndrome | 2.7% |
| 331 | Corpus Luteum Cyst | 2.7% |
| 332 | Ovarian Cysts | 2.7% |
| 333 | Wiskott-Aldrich Syndrome | 2.7% |
| 334 | Vitamin K Deficiency | 2.7% |
| 335 | insulinoma | 2.7% |
| 336 | Hydrops Fetalis | 2.6% |
| 337 | Thrombocytosis | 2.6% |
| 338 | Job Syndrome | 2.6% |
| 339 | Kernicterus | 2.6% |
| 340 | Afibrinogenemia | 2.5% |
| 341 | Factor VII Deficiency | 2.5% |
| 342 | Factor X Deficiency | 2.5% |
| 343 | Factor XII Deficiency | 2.5% |
| 344 | Hemophilia A | 2.5% |
| 345 | Activated Protein C Resistance | 2.5% |
| 346 | Factor II deficiency | 2.5% |
| 347 | Factor VIII Deficiency | 2.5% |
| 348 | Factor V deficiency | 2.5% |
| 349 | Factor XI Deficiency | 2.5% |
| 350 | Hypoprothrombinemias | 2.5% |
| 351 | Pancreatic Neoplasm | 2.5% |
| 352 | Latent Autoimmune Diabetes in Adults | 2.5% |
| 353 | Dermatitis Herpetiformis | 2.5% |
| 354 | Kounis Syndrome | 2.5% |
| 355 | HIV Infections | 2.5% |
| 356 | Eosinophilic Granuloma | 2.4% |
| 357 | Splenosis | 2.4% |
| 358 | Retroperitoneal Neoplasms | 2.4% |
| 359 | Adrenocortical carcinoma | 2.4% |
| 360 | Gastrinoma | 2.4% |
| 361 | Glucagonoma | 2.4% |
| 362 | Choledochal Cyst | 2.4% |
| 363 | Tracheal Neoplasms | 2.4% |
| 364 | Peutz-Jeghers Syndrome | 2.3% |
| 365 | Leukoplakia, Oral | 2.3% |
| 366 | Nasopharyngeal carcinoma | 2.3% |
| 367 | Paraneoplastic Cerebellar Degeneration | 2.3% |
| 368 | Leydig Cell Tumor | 2.3% |
| 369 | Denys-Drash Syndrome | 2.2% |
| 370 | Chronic granulomatous disease | 2.2% |
| 371 | Rheumatoid Arthritis | 2.1% |
| 372 | Juvenile arthritis | 2.1% |
| 373 | Renal Cell Carcinoma | 2.1% |
| 374 | Papillary Renal Cell Carcinoma | 2.1% |
| 375 | Graves Disease | 2.1% |
| 376 | Anti-Glomerular Basement Membrane Disease | 2.1% |
| 377 | Asthma, Aspirin-Induced | 2% |
| 378 | Dupuytren Contracture | 2% |
| 379 | Esophageal Neoplasms | 2% |
| 380 | Carcinoma, Endometrioid | 2% |
| 381 | Limbic Encephalitis | 2% |
| 382 | anaphylaxis | 2% |
| 383 | Anemia, Hemolytic | 2% |
| 384 | Anemia, Macrocytic | 2% |
| 385 | Eosinophilia | 2% |
| 386 | Food Allergy | 2% |
| 387 | Hypoproteinemia | 2% |
| 388 | Leukopenia | 2% |
| 389 | Thrombocytopenia | 2% |
| 390 | Leukostasis | 2% |
| 391 | MYELODYSPLASTIC SYNDROME | 2% |
| 392 | Anaphylactic shock | 2% |
| 393 | Urticaria Pigmentosa | 2% |
| 394 | Mouth Neoplasms | 2% |
| 395 | Central Nervous System Neoplasms | 2% |
| 396 | Vascular Neoplasms | 2% |
| 397 | Genital Neoplasms, Female | 1.9% |
| 398 | Pancreatic Pseudocyst | 1.9% |
| 399 | Lymphatic Metastasis | 1.9% |
| 400 | Neoplasms, Unknown Primary | 1.9% |
| 401 | Leukemic Infiltration | 1.9% |
| 402 | Breast Neoplasms, Male | 1.9% |
| 403 | Neoplasm Micrometastasis | 1.9% |
| 404 | Triple Negative Breast Neoplasms | 1.9% |
| 405 | Hemoglobinuria, Paroxysmal | 1.9% |
| 406 | Leukemoid Reaction | 1.9% |
| 407 | Myelitis, Transverse | 1.9% |
| 408 | Thyroid Nodule | 1.9% |
| 409 | Serum Sickness | 1.8% |
| 410 | Testicular Neoplasms | 1.8% |
| 411 | Purpura, Thrombotic Thrombocytopenic | 1.7% |
| 412 | Respiratory Hypersensitivity | 1.7% |
| 413 | Adrenal Gland Neoplasms | 1.7% |
| 414 | Gastrointestinal Neoplasms | 1.7% |
| 415 | Genital Neoplasms, Male | 1.7% |
| 416 | Liver neoplasms | 1.7% |
| 417 | Uveal Neoplasms | 1.7% |
| 418 | Urologic Neoplasms | 1.6% |
| 419 | Anemia, Neonatal | 1.6% |
| 420 | Leukocytosis | 1.6% |
| 421 | Pelger-Huet Anomaly | 1.6% |
| 422 | Sick Building Syndrome | 1.6% |
| 423 | Pleocytosis | 1.6% |
| 424 | Multiple Chemical Sensitivity | 1.6% |
| 425 | Opsoclonus-Myoclonus Syndrome | 1.6% |
| 426 | Sebaceous Gland Neoplasms | 1.6% |
| 427 | Spinal Neoplasms | 1.6% |
| 428 | Anemia, Sickle Cell | 1.6% |
| 429 | Thalassemia | 1.6% |
| 430 | Urticaria | 1.6% |
| 431 | Vasculitis, Leukocytoclastic, Cutaneous | 1.6% |
| 432 | HTLV-I Infections | 1.6% |
| 433 | Polycystic Ovary Syndrome | 1.6% |
| 434 | Anemia, Diamond-Blackfan | 1.6% |
| 435 | Xeroderma Pigmentosum | 1.5% |
| 436 | Ataxia Telangiectasia | 1.5% |
| 437 | Myasthenia Gravis | 1.4% |
| 438 | Uveomeningoencephalitic Syndrome | 1.4% |
| 439 | Drug Eruptions | 1.4% |
| 440 | Ecchymosis | 1.4% |
| 441 | Petechiae | 1.4% |
| 442 | Purpura | 1.4% |
| 443 | Granulomatosis with polyangiitis | 1.3% |
| 444 | Dermatitis, Allergic Contact | 1.3% |
| 445 | HIV Seropositivity | 1.3% |
| 446 | Nose Neoplasms | 1.3% |
| 447 | Meningeal Neoplasms | 1.3% |
| 448 | Palatal Neoplasms | 1.3% |
| 449 | ovarian neoplasm | 1.2% |
| 450 | Pituitary Adenoma | 1.2% |
| 451 | Pituitary Neoplasms | 1.2% |
| 452 | Purpura, Hyperglobulinemic | 1.2% |
| 453 | Primary Myelofibrosis | 1.2% |
| 454 | Agranulocytosis | 1.2% |
| 455 | Anemia, Megaloblastic | 1.2% |
| 456 | Lymphocytosis | 1.2% |
| 457 | Myelofibrosis | 1.2% |
| 458 | Myeloid Metaplasia | 1.2% |
| 459 | Milk Allergy | 1.2% |
| 460 | Hypoalbuminemia | 1.2% |
| 461 | Wheat Hypersensitivity | 1.2% |
| 462 | Hypereosinophilic syndrome | 1.2% |
| 463 | bone marrow fibrosis | 1.2% |
| 464 | Thrombotic Microangiopathies | 1.2% |
| 465 | Stiff-Person Syndrome | 1.2% |
| 466 | Polyradiculoneuropathy | 1.2% |
| 467 | Polyradiculoneuritis | 1.2% |
| 468 | Acquired Immunodeficiency Syndrome | 1.2% |
| 469 | AIDS related complex | 1.2% |
| 470 | Felty Syndrome | 1.2% |
| 471 | Lupus Nephritis | 1.2% |
| 472 | Hemolytic-Uremic Syndrome | 1.1% |
| 473 | Ear Neoplasms | 1.1% |
| 474 | Eyelid Neoplasms | 1.1% |
| 475 | Lung Neoplasms | 1.1% |
| 476 | Pleural Neoplasms | 1.1% |
| 477 | Cell Transformation, Viral | 1.1% |
| 478 | Brain Neoplasms | 1.1% |
| 479 | Salivary Gland Neoplasms | 1.1% |
| 480 | Spinal Cord Neoplasms | 1.1% |
| 481 | Tongue Neoplasms | 1.1% |
| 482 | Myasthenia Gravis, Autoimmune, Experimental | 1.1% |
| 483 | Waterhouse-Friderichsen Syndrome | 1.1% |
| 484 | Uterine Neoplasms | 1.1% |
| 485 | Vaginal Neoplasms | 1.1% |
| 486 | Vulvar Neoplasms | 1.1% |
| 487 | Uterine Cancer | 1.1% |
| 488 | Fallopian Tube Neoplasms | 1.1% |
| 489 | AIDS-Related Opportunistic Infections | 1% |
| 490 | Vasculitis, Central Nervous System | 1% |
| 491 | Sickle Cell Trait | 1% |
| 492 | Dermatitis, Atopic | 1% |
| 493 | HIV Wasting Syndrome | 1% |
| 494 | Rheumatoid Vasculitis | 1% |
| 495 | AIDS Dementia Complex | 1% |
| 496 | AIDS-Associated Nephropathy | 1% |
| 497 | Zollinger-Ellison syndrome | 1% |
| 498 | Meningeal Carcinomatosis | 1% |
| 499 | Pharyngeal Neoplasms | 1% |
| 500 | Central Nervous System Cysts | 0.9% |
| 501 | Bile Duct Neoplasms | 0.9% |
| 502 | gallbladder neoplasm | 0.9% |
| 503 | Intestinal Neoplasms | 0.9% |
| 504 | Penile Neoplasms | 0.9% |
| 505 | Prostatic Neoplasms | 0.9% |
| 506 | Stomach Neoplasms | 0.9% |
| 507 | Lupus Vasculitis, Central Nervous System | 0.9% |
| 508 | Fanconi Anemia | 0.9% |
| 509 | Sicca Syndrome | 0.9% |
| 510 | Sjogren's Syndrome | 0.9% |
| 511 | HIV-Associated Lipodystrophy Syndrome | 0.9% |
| 512 | Laryngeal neoplasm | 0.8% |
| 513 | Eosinophilia-Myalgia Syndrome | 0.8% |
| 514 | Acute Chest Syndrome | 0.8% |
| 515 | Bronchial Neoplasms | 0.8% |
| 516 | Angioedema | 0.8% |
| 517 | Multiple Sclerosis | 0.8% |
| 518 | Shwartzman Phenomenon | 0.8% |
| 519 | Bladder Neoplasm | 0.8% |
| 520 | Kidney Neoplasm | 0.8% |
| 521 | Ureteral Neoplasms | 0.8% |
| 522 | Urethral Neoplasms | 0.8% |
| 523 | Multiple Pulmonary Nodules | 0.8% |
| 524 | Scurvy | 0.8% |
| 525 | Purpura Fulminans | 0.8% |
| 526 | Acute Generalized Exanthematous Pustulosis | 0.8% |
| 527 | Supratentorial Neoplasms | 0.8% |
| 528 | Neutropenia | 0.8% |
| 529 | Endometrial Neoplasms | 0.8% |
| 530 | Atypical Hemolytic Uremic Syndrome | 0.8% |
| 531 | Neuromyelitis Optica | 0.7% |
| 532 | Leukoencephalitis, Acute Hemorrhagic | 0.7% |
| 533 | Niemann-Pick Disease, Type C | 0.7% |
| 534 | Asthma | 0.7% |
| 535 | Hypopharyngeal Neoplasms | 0.7% |
| 536 | Pleural Effusion, Malignant | 0.7% |
| 537 | Hypopharyngeal Cancer | 0.7% |
| 538 | Encephalomyelitis, Acute Disseminated | 0.7% |
| 539 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 0.7% |
| 540 | Erythema Nodosum | 0.7% |
| 541 | Neuritis, Autoimmune, Experimental | 0.7% |
| 542 | Dermatitis, Photoallergic | 0.7% |
| 543 | Parotid Neoplasms | 0.7% |
| 544 | Prostatic Neoplasms, Castration-Resistant | 0.7% |
| 545 | Nelson Syndrome | 0.7% |
| 546 | Brain Stem Neoplasms | 0.7% |
| 547 | Pulmonary Eosinophilia | 0.7% |
| 548 | Eosinophilic Pneumonia | 0.7% |
| 549 | Anemia, Pernicious | 0.6% |
| 550 | Aspergillosis, Allergic Bronchopulmonary | 0.6% |
| 551 | Guillain-Barre Syndrome | 0.6% |
| 552 | Cecal Neoplasms | 0.6% |
| 553 | Duodenal Neoplasms | 0.6% |
| 554 | Febrile Neutropenia | 0.6% |
| 555 | Choroid Plexus Papilloma | 0.6% |
| 556 | Tonsillar Neoplasms | 0.6% |
| 557 | Cerebellar Neoplasms | 0.6% |
| 558 | Nasopharyngeal Neoplasms | 0.5% |
| 559 | Asthma, Exercise-Induced | 0.5% |
| 560 | Status Asthmaticus | 0.5% |
| 561 | Toxic Epidermal Necrolysis | 0.5% |
| 562 | Stevens-Johnson Syndrome | 0.5% |
| 563 | Colorectal Neoplasms | 0.5% |
| 564 | Multiple Sclerosis, Chronic Progressive | 0.5% |
| 565 | Multiple Sclerosis, Relapsing-Remitting | 0.5% |
| 566 | Radicular Cyst | 0.5% |
| 567 | Appendiceal Neoplasms | 0.5% |
| 568 | Colonic Neoplasms | 0.5% |
| 569 | Rectal Neoplasms | 0.5% |
| 570 | Pseudoxanthoma Elasticum | 0.5% |
| 571 | Paranasal Sinus Neoplasms | 0.5% |
| 572 | Giant Cell Arteritis | 0.5% |
| 573 | Temporal Arteritis | 0.5% |
| 574 | Asthma, Occupational | 0.5% |
| 575 | Farmer's Lung | 0.5% |
| 576 | Angioedemas, Hereditary | 0.5% |
| 577 | Hay fever | 0.5% |
| 578 | Rhinitis, Allergic, Perennial | 0.5% |
| 579 | Maxillary Sinus Neoplasms | 0.4% |
| 580 | Hereditary Angioedema Type III | 0.4% |
| 581 | Hereditary Angioedema Types I and II | 0.4% |
| 582 | Anus Neoplasms | 0.4% |
| 583 | Sigmoid Neoplasms | 0.4% |
| 584 | Miller Fisher Syndrome | 0.3% |
